State
72,940 recalls have nationwide distribution and so reach Florida. 12,818 additional recalls listed Florida specifically in their distribution scope.
Of the 12,818 recalls naming Florida we have scored against our rubric, 1,764 (14%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2,975 (23%) are Severe.
Which agencies issued them
These figures cover only the 12,818 recalls whose distribution notice names Florida specifically. The 72,940 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Daye is recalling 3,074 packs of 18 Coated Super Tampons because the product lacks 510(k) clearance.
Daye is recalling 3,074 packs of its Heavy Flow Bundle because the product lacks 510(k) clearance.
Daye is recalling 3,074 packs of 9 Coated Regular Tampons and 9 Nude Regular Tampons because the product lacks 510(k) clearance.
Daye is recalling 3,074 packs of Initiation 18 Coated Super and 18 Nude Super Tampons because the product lacks 510(k) clearance.
Daye is recalling 3,074 packs of its Refill 3 Month Regular Flow Bundle because the product lacks 510(k) clearance.
Daye is recalling 3,074 packs of its Initiation 3 Month All in One Bundle because the product lacks 510(k) clearance.
Daye is recalling 3,074 packs of its Trial Tampon Box because the product lacks 510(k) clearance.
Daye is recalling 3,074 packs of its Refill 3 Month Trial Tampon Box because the product lacks 510(k) clearance.
Daye is recalling 3,074 packs of 9 Coated Super and 9 Nude Super Tampons because the product lacks 510(k) clearance.
Daye is recalling 3,074 packs of its Initiation 3 Month Regular Flow Bundle because the product lacks 510(k) clearance.
Endo USA is recalling 6,655 cartons of Everolimus tablets 5 mg after results came back out of specification for impurity IP-C.
Kenvue Brands is recalling 3,816 bottles of Extra Strength TYLENOL 500mg caplets, 24-count, from one lot because of a defective container.
Endo USA is recalling 1,866 cartons of Everolimus tablets 7.5 mg after results came back out of specification for impurity IP-C.
Greiner Bio-One is recalling 504,000 VACUETTE 2 ml coagulation tubes because the label was applied too high, shifting the printed fill level mark upward.
Daye is recalling 3,074 packs of its Initiation 3 Month Heavy Flow Bundle because the product lacks 510(k) clearance.
Daye is recalling 3,074 packs of its Regular Flow Bundle because the product lacks 510(k) clearance.
Daye is recalling 3,074 packs of 9 Coated Regular and 9 Nude Regular Tampons because the product lacks 510(k) clearance.
Endo USA is recalling 935 cartons of Everolimus tablets 10 mg after results came back out of specification for impurity IP-C.
Endo USA is recalling 2,035 cartons of Everolimus tablets 2.5 mg after results came back out of specification for impurity IP-C.
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 60 mg after an out-of-specification dissolution result at the 12-month stability station.
Daye is recalling 3,074 packs of 18 Coated Regular Tampons because the product lacks 510(k) clearance.
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 50 mg after an out-of-specification dissolution result at the 12-month stability station.
Daye is recalling 3,074 packs of its Refill 3 Month All in One Bundle because the product lacks 510(k) clearance.
Daye is recalling 3,074 packs of Initiation 18 Coated Regular and 18 Nude Regular Tampons because the product lacks 510(k) clearance.
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 10 mg after an out-of-specification dissolution result at the 12-month stability station.